Lv22
140 积分 2022-10-25 加入
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
5小时前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
1天前
已完结
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
1天前
已完结
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
1天前
已完结
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
6天前
已完结
[Consensus on targeted drug therapy for spondyloarthritis]
6天前
已完结
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis
6天前
已完结
中轴型脊柱关节炎诊断和治疗专家共识
6天前
已完结
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
7天前
已完结
Advances in HPV‐associated tumor management: Therapeutic strategies and emerging insights
7天前
已完结
皖公网安备34019202002308
